Synthesis and anticonvulsant activities of (R)-N-(4'-substituted)benzyl 2-acetamido-3-methoxypropionamides. 2010

Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
Division of Medicinal Chemistry and Natural Products, University of North Carolina Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568, USA.

The structure-activity relationship (SAR) for the N-benzyl group in the clinical antiepileptic agent (R)-lacosamide [(R)-N-benzyl 2-acetamido-3-methoxypropionamide, (R)-3] has been explored. Forty-three compounds were prepared and then evaluated at the National Institute of Neurological Disorders and Stroke Anticonvulsant Screening Program for seizure protection in the maximal electroshock (MES) and subcutaneous Metrazol models. Comparing activities for two series of substituted aryl regioisomers (2', 3', 4') showed that 4'-modified derivatives had the highest activity. Significantly, structural latitude existed at the 4'-site. The SAR indicated that nonbulky 4'-substituted (R)-3 derivatives exhibited superb activity, independent of their electronic properties. Activities in the MES test of several compounds were comparable with or exceeded that of (R)-3 and surpassed the activities observed for the traditional antiepileptic agents phenytoin, phenobarbital, and valproate.

UI MeSH Term Description Entries
D007696 Kindling, Neurologic The repeated weak excitation of brain structures, that progressively increases sensitivity to the same stimulation. Over time, this can lower the threshold required to trigger seizures. Kindlings, Neurologic,Neurologic Kindling,Neurologic Kindlings
D008297 Male Males
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D003292 Convulsants Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. Convulsant,Convulsant Effect,Convulsant Effects,Effect, Convulsant,Effects, Convulsant
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004597 Electroshock Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. Electroconvulsive Shock,Electroconvulsive Shocks,Electroshocks,Shock, Electroconvulsive,Shocks, Electroconvulsive
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
October 2008, Bioorganic & medicinal chemistry,
Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
February 2009, European journal of medicinal chemistry,
Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
January 2003, Polish journal of pharmacology,
Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
April 1996, Journal of medicinal chemistry,
Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
December 1996, Bioorganic & medicinal chemistry,
Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
November 1999, Bioorganic & medicinal chemistry,
Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
June 1975, Journal of pharmaceutical sciences,
Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
June 2011, European journal of medicinal chemistry,
Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
October 1993, Journal of medicinal chemistry,
Christophe Salomé, and Elise Salomé-Grosjean, and Ki Duk Park, and Pierre Morieux, and Robert Swendiman, and Erica DeMarco, and James P Stables, and Harold Kohn
January 2012, European journal of medicinal chemistry,
Copied contents to your clipboard!